SV Health Investors — 2014 Investments

5 investments dated 2014 · listed companies and verified rows first · show all

ValenTxvalentx.comSeries B · Jul 2014 · $22M

BiotechMaple Grove, US

JON PATRICK ST. GERMAIN(Executive Officer)DAVID KRENN(Executive Officer)JOHANN NEISZ(Executive Officer, Director)

BoardMARY LINCOLN CAMPBELL(Director)MITCHELL DANN(Director)PAUL A. LAVIOLETTE(Director)in

Board seat Paul LaViolette· per SEC Form D

Co-investorsKaiser Permanente Ventures

Thesan Pharmaceuticals inSeries B · Feb 2014 · $49M

BiotechCarlsbad, US

John Gordon Foulkes(Executive Officer, Director)

BoardMette Agger(Director)Peter Bisgaard(Director)Giovanni Ferrara(Director)Tiba Aynechi(Director)Michael Ross(Director)

Co-investorsNovartis Venture Fund SV Life Sciences

TrialScope inJun 2014 · $10M

BiotechJersey City, US

Mark Heinold(Executive Officer, Director)inRichard Aguinaldo(Executive Officer)E. Michael Forgash(Executive Officer, Director)

Board Michael A DiPiano(Director)inEric Jensen(Director)Joe Stauffer(Director)

Co-investorsEdison Partners NewSpring Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AqueSys CardioKinetix

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.